Joseph Payne, President & CEO, will present at a Fireside Chat hosted by the H.C. Wainwright Global Life Sciences Conference
Joseph Payne, President & CEO, will present at a Fireside Chat hosted by the Barclays Global Healthcare Conference
Arcturus Therapeutics will present LUNAR-OTC poster at the upcoming Society for Inhereited Metabolic Disorders (SIMD) Conference
Pad Chivukula, CSO and COO, will be a scientific organizer at the 2019 Keystone Symposia on Protein Replacement
Joseph Payne, President and CEO, will present at JLABS
Joseph Payne, President & CEO, will present at the 31st Annual ROTH Conference
Joseph Payne, President & CEO, will present at the Leerink 8th Annual Global Healthcare Conference
Joe Payne, President & CEO of Arcturus Therapeutics, will be Moderating the Fireside Chat at the East/West CEO Conference, with the Head of J&J innovation California, Rowan Chapman, Titled “Innovation and Strategic Growth Strategies for Biopharma"
The call will feature a presentation by key opinion leader Annette Feigenbaum, MBChB, FRCP, DABMG (UC San Diego), who will discuss the disease pathogenesis, manifestation, natural history and current treatment options for Ornithine transcarbamylase (OTC) deficiency. Dr. Feigenbaum will be available to answer questions at the conclusion of the call.
Dr. Pad Chivukula, Chief Scientific Officer of Arcturus Therapeutics, will also provide a brief overview of the company's LUNAR-OTC program, which utilizes the company's proprietary LUNAR® delivery platform to safely and effectively deliver OTC mRNA to liver cells, resulting in restoration of disease markers to normal levels.